agilon health (NYSE:AGL) Trading Down 6.6% – Here’s Why

Shares of agilon health, inc. (NYSE:AGL) were down 6.6% during mid-day trading on Friday . The company traded as low as $3.11 and last traded at $3.13. Approximately 1,039,670 shares were traded during trading, a decline of 81% from the average daily volume of 5,475,114 shares. The stock had previously closed at $3.35.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on AGL shares. Macquarie started coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday. TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Finally, Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $3.95.

agilon health Stock Performance

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $1.29 billion, a PE ratio of -3.32 and a beta of 0.67. The firm’s fifty day simple moving average is $2.96 and its 200 day simple moving average is $3.01.

Insider Buying and Selling at agilon health

In other agilon health news, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 77,500 shares of company stock valued at $169,600. 3.20% of the stock is owned by insiders.

Institutional Investors Weigh In On agilon health

Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC boosted its stake in shares of agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after acquiring an additional 112,241 shares in the last quarter. Citigroup Inc. boosted its stake in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in shares of agilon health during the 4th quarter worth about $97,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.